Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $81.91 as of April 9th. MRK’s trailing and forward P/E were 12.15 and 9.10 respectively according to Yahoo Finance.

Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks’ Oaktree Capital Management?

David Smart/Shutterstock.com

Merck (MRK) is emerging from 2024 with strong momentum, posting 7% revenue growth fueled by its expanding oncology and cardiovascular franchises—key...